Cook Meredith 4

What Happened Meredith Cook, Senior Vice President, General Counsel & Secretary of ANI Pharmaceuticals (ANIP), sold 500 shares in an open-market transaction on March 13, 2026. The shares were sold at $72.62 each for total gross proceeds of $36,310. This was a sale (not a purchase); the filing notes the trade was executed under a pre-established Rule 10b5-1 trading plan.

Key Details

• Transaction date: 2026-03-13; Type: Sale (open market); Price: $72.62; Shares: 500; Value: $36,310.
• Shares owned after transaction: not disclosed in the provided Form 4.
• Footnote: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.
• Filing timeliness: Reported on March 13, 2026 (same day as the transaction date in the filing), no late-filing indication in the provided data.
• Transaction code: S (sale).

Context This was a routine insider sale executed under a 10b5-1 plan, which allows scheduled trades regardless of subsequent company developments. Such sales do not by themselves indicate the insider’s view of the company’s prospects. Retail investors often view purchases as stronger signals than routine sales.